COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

Even seeing a cardiologist once per year can help these patients elevate their long-term survival. Many stay home, however, missing out on potentially life-saving guidance and/or treatment.

Specialists with Duke University Medical System will participate in a free webinar focused on their experience treating heart failure with the implantable Barostim technology from CVRx.

Cannabis use can be especially harmful for heart failure patients, according to new data presented at SCAI 2025.

Researchers examined data from more than 9,000 patients, sharing their findings at SCAI 2025.

Researchers tracked short- and long-term data from nearly 2,000 patients, presenting their findings in JACC: Heart Failure. 

New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.

CDC data shows that mortality from heart failure-related cardiac arrest has decreased significantly in the last 25 years. However, researchers noted, care teams still have considerable work to do.